Rhenman & Partners Asset Management AB as of March 31, 2017
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 104 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Horizon Pharma | 4.1 | $26M | 1.8M | 14.78 | |
Esperion Therapeutics (ESPR) | 3.0 | $19M | 543k | 35.31 | |
Biogen Idec (BIIB) | 2.9 | $19M | 68k | 273.43 | |
Glaukos (GKOS) | 2.6 | $17M | 326k | 51.30 | |
Amgen (AMGN) | 2.6 | $16M | 100k | 164.07 | |
Incyte Corporation (INCY) | 2.4 | $15M | 115k | 133.67 | |
Abiomed | 2.3 | $15M | 117k | 125.20 | |
Medtronic (MDT) | 2.3 | $15M | 181k | 80.56 | |
Regeneron Pharmaceuticals (REGN) | 2.3 | $14M | 37k | 387.51 | |
Eli Lilly & Co. (LLY) | 2.3 | $14M | 170k | 84.11 | |
Gilead Sciences (GILD) | 2.2 | $14M | 207k | 67.92 | |
Allergan | 2.2 | $14M | 59k | 238.92 | |
Exelixis (EXEL) | 2.2 | $14M | 630k | 21.67 | |
Alexion Pharmaceuticals | 2.1 | $14M | 112k | 121.24 | |
Intra Cellular Therapies (ITCI) | 1.8 | $12M | 716k | 16.25 | |
Celgene Corporation | 1.8 | $12M | 93k | 124.43 | |
Endologix | 1.8 | $12M | 1.6M | 7.24 | |
Pfizer (PFE) | 1.8 | $12M | 335k | 34.21 | |
Nektar Therapeutics (NKTR) | 1.8 | $11M | 470k | 23.47 | |
BioMarin Pharmaceutical (BMRN) | 1.7 | $11M | 125k | 87.78 | |
Bristol Myers Squibb (BMY) | 1.7 | $11M | 201k | 54.38 | |
UnitedHealth (UNH) | 1.7 | $11M | 65k | 164.02 | |
Nevro (NVRO) | 1.7 | $11M | 113k | 93.70 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $10M | 95k | 109.35 | |
CVS Caremark Corporation (CVS) | 1.6 | $10M | 130k | 78.50 | |
Merck & Co (MRK) | 1.6 | $10M | 160k | 63.54 | |
CIGNA Corporation | 1.5 | $9.4M | 64k | 146.48 | |
Hca Holdings (HCA) | 1.5 | $9.3M | 105k | 88.99 | |
Jazz Pharmaceuticals (JAZZ) | 1.4 | $8.8M | 60k | 145.13 | |
Kite Pharma | 1.4 | $8.6M | 110k | 78.49 | |
Zimmer Holdings (ZBH) | 1.4 | $8.5M | 70k | 122.11 | |
Abbvie (ABBV) | 1.3 | $8.5M | 130k | 65.16 | |
Alkermes (ALKS) | 1.3 | $8.2M | 140k | 58.50 | |
Supernus Pharmaceuticals (SUPN) | 1.1 | $7.2M | 230k | 31.30 | |
Alnylam Pharmaceuticals (ALNY) | 1.1 | $6.7M | 130k | 51.25 | |
Aetna | 1.1 | $6.6M | 52k | 127.56 | |
Humana (HUM) | 1.0 | $6.6M | 32k | 206.12 | |
Hologic (HOLX) | 1.0 | $6.4M | 150k | 42.55 | |
Express Scripts Holding | 1.0 | $6.3M | 96k | 65.91 | |
Centene Corporation (CNC) | 1.0 | $6.2M | 88k | 71.26 | |
Xencor (XNCR) | 1.0 | $6.2M | 260k | 23.92 | |
Anthem (ELV) | 1.0 | $6.2M | 38k | 165.37 | |
Cardinal Health (CAH) | 1.0 | $6.1M | 75k | 81.55 | |
Thermo Fisher Scientific (TMO) | 1.0 | $6.1M | 40k | 153.60 | |
Dynavax Technologies (DVAX) | 0.9 | $5.9M | 985k | 5.95 | |
Edwards Lifesciences (EW) | 0.9 | $5.6M | 60k | 94.07 | |
AmerisourceBergen (COR) | 0.9 | $5.6M | 63k | 88.51 | |
Sage Therapeutics (SAGE) | 0.8 | $5.2M | 73k | 71.07 | |
Abbott Laboratories (ABT) | 0.8 | $5.1M | 115k | 44.41 | |
Lion Biotechnologies | 0.8 | $4.8M | 650k | 7.45 | |
Dex (DXCM) | 0.8 | $4.8M | 57k | 84.73 | |
Portola Pharmaceuticals | 0.8 | $4.7M | 121k | 39.19 | |
Endo International | 0.7 | $4.5M | 402k | 11.16 | |
Universal Health Services (UHS) | 0.7 | $4.4M | 35k | 124.46 | |
Revance Therapeutics (RVNC) | 0.7 | $4.4M | 210k | 20.80 | |
Rigel Pharmaceuticals | 0.7 | $4.2M | 1.3M | 3.31 | |
NxStage Medical | 0.7 | $4.1M | 154k | 26.83 | |
Omnicell (OMCL) | 0.6 | $4.0M | 99k | 40.65 | |
Aerie Pharmaceuticals | 0.6 | $3.9M | 85k | 45.35 | |
Fibrogen (FGEN) | 0.6 | $3.8M | 154k | 24.65 | |
DaVita (DVA) | 0.6 | $3.7M | 55k | 67.96 | |
Walgreen Boots Alliance (WBA) | 0.6 | $3.7M | 45k | 83.04 | |
Neurocrine Biosciences (NBIX) | 0.6 | $3.7M | 85k | 43.31 | |
Mylan Nv | 0.6 | $3.5M | 90k | 38.99 | |
Intercept Pharmaceuticals In | 0.5 | $3.4M | 30k | 113.10 | |
Macrogenics (MGNX) | 0.5 | $3.3M | 175k | 18.60 | |
Array BioPharma | 0.5 | $3.1M | 350k | 8.94 | |
Laboratory Corp. of America Holdings | 0.5 | $3.1M | 22k | 143.48 | |
Intuitive Surgical (ISRG) | 0.5 | $3.1M | 4.0k | 766.50 | |
Immunomedics | 0.5 | $3.1M | 480k | 6.47 | |
ACADIA Pharmaceuticals (ACAD) | 0.5 | $3.1M | 90k | 34.38 | |
Radius Health | 0.5 | $2.9M | 75k | 38.65 | |
Tetraphase Pharmaceuticals | 0.4 | $2.8M | 300k | 9.19 | |
Adamas Pharmaceuticals | 0.4 | $2.7M | 155k | 17.50 | |
Keryx Biopharmaceuticals | 0.4 | $2.6M | 425k | 6.16 | |
Chimerix (CMRX) | 0.4 | $2.6M | 400k | 6.38 | |
Coherus Biosciences (CHRS) | 0.4 | $2.4M | 111k | 21.15 | |
Halozyme Therapeutics (HALO) | 0.3 | $2.2M | 170k | 12.96 | |
Bioverativ Inc Com equity | 0.3 | $1.7M | 31k | 54.45 | |
Insulet Corporation (PODD) | 0.2 | $1.5M | 35k | 43.09 | |
Regulus Therapeutics | 0.2 | $980k | 594k | 1.65 | |
Becton, Dickinson and (BDX) | 0.1 | $917k | 5.0k | 183.40 | |
Tesaro | 0.1 | $769k | 5.0k | 153.80 | |
Achillion Pharmaceuticals | 0.1 | $699k | 166k | 4.21 | |
Concert Pharmaceuticals I equity | 0.1 | $513k | 30k | 17.04 | |
Catabasis Pharmaceuticals | 0.1 | $497k | 311k | 1.60 | |
JPMorgan Chase & Co. (JPM) | 0.1 | $425k | 4.8k | 87.86 | |
Adverum Biotechnologies | 0.1 | $416k | 154k | 2.70 | |
Orexigen Therapeutics | 0.1 | $413k | 120k | 3.44 | |
Exxon Mobil Corporation (XOM) | 0.1 | $396k | 4.8k | 82.11 | |
Wells Fargo & Company (WFC) | 0.1 | $407k | 7.3k | 55.72 | |
Halliburton Company (HAL) | 0.1 | $380k | 7.7k | 49.24 | |
Ocular Therapeutix (OCUL) | 0.1 | $371k | 40k | 9.28 | |
Microsoft Corporation (MSFT) | 0.1 | $316k | 4.8k | 65.93 | |
International Business Machines (IBM) | 0.1 | $308k | 1.8k | 174.41 | |
Qualcomm (QCOM) | 0.1 | $308k | 5.4k | 57.38 | |
Anheuser-Busch InBev NV (BUD) | 0.1 | $308k | 2.8k | 109.76 | |
STAAR Surgical Company (STAA) | 0.0 | $281k | 29k | 9.79 | |
Ford Motor Company (F) | 0.0 | $262k | 23k | 11.64 | |
Mirati Therapeutics | 0.0 | $260k | 50k | 5.20 | |
Tandem Diabetes Care | 0.0 | $281k | 234k | 1.20 | |
Threshold Pharmaceuticals | 0.0 | $115k | 202k | 0.57 | |
Anthera Pharmaceutcls | 0.0 | $84k | 200k | 0.42 | |
Ophthotech | 0.0 | $88k | 24k | 3.68 |